Maxcyte (MXCT) Finished Goods (2020 - 2026)

Maxcyte (MXCT) has 7 years of Finished Goods data on file, last reported at $3.5 million in Q1 2026.

• Finished Goods for Q1 2026 came in at $3.5 million, down 3.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (down 3.08% YoY), and the FY2025 annual result was $3.2 million, down 18.97% from the prior year.
• Finished Goods advanced to $3.5 million in Q1 2026 per MXCT's latest filing, from $3.2 million in the prior quarter.
• Over five years, Finished Goods peaked at $6.0 million in Q1 2024 and troughed at $2.7 million in Q3 2022.
• A 5-year average of $4.0 million and a median of $3.5 million in 2023 frame the typical range for Finished Goods.
• The sharpest annual moves came in 2023 and 2025: Finished Goods soared 121.46% in 2023, then sank 40.19% in 2025.
• A 5-year view of Finished Goods shows it stood at $2.9 million in 2022, then soared by 103.99% to $6.0 million in 2023, then sank by 34.3% to $3.9 million in 2024, then retreated by 18.97% to $3.2 million in 2025, then gained by 9.87% to $3.5 million in 2026.
• Business Quant data shows MXCT's Finished Goods at $3.5 million in Q1 2026, $3.2 million in Q4 2025, and $3.3 million in Q3 2025.